2022 Winter GAPNA Newsletter Volume 41 Number 4

Alzheimer’s Disease Risk Doubles After COVID-19 Infection

A study published in the Journal of Alzheimer’s Disease found adults aged 65 and older who had COVID-19 were more at risk for developing Alzheimer’s disease in the year following their COVID-19 diagnosis.

In the study of over 6 million patients aged 65 and older, researchers found that this age group is at a substantially higher risk – 50% to 80% higher than the control group ­– of developing Alzheimer’s after COVID-19.

Researchers are unclear whether COVID-19 activates new development of Alzheimer’s disease or accelerates its emergence.

Read more about the study.